Fortress Biotech Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
FBIO$1.99+7.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
CONSOLIDATED FINANCIAL STATEMENTS
Index to Consolidated Financial Statements
| Reports of Independent Registered Public Accounting Firms (KPMG LLP, Short Hills, NJ; PCAOB No.: 185) | F-2 |
|---|---|
| | |
| Consolidated Balance Sheets | F-5 |
| | |
| Consolidated Statements of Operations | F-6 |
| | |
| Consolidated Statements of Changes in Stockholders’ Equity | F-7 |
| | |
| Consolidated Statements of Cash Flows | F-9 |
| | |
| Notes to the Consolidated Financial Statements | F-11 – F-59 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.